drugset / Trial / NCT02674906

Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)

NCT02674906

Completed 75 enrolled Ziekenhuis Oost-Limburg
RandomizedParallel-groupSingle-blindOther

Summary

The primary aim of this randomized controlled study is to determine whether the use Anticoagulant Citrate Dextrose Solution--Formula A (ACD-A) in cell salvage reduces inflammation and oxidative stress in cell saver blood compared to heparin. The secondary aim is to determine whether any differences in activation can be correlated to any differences in postoperative clinical outcome.

Timeline

Start
2016-02
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator ACD-A Unknown 20 ml
Comparator Heparin Other / unclassified 20 ml

Indications

No indication recorded.